The recent glioma classification is based on the status of mutations of isocitrate dehydrogenase genes 1 and 2 (IDH1/2), 1p/19q co-deletion, ATRX alterations, and TERT promoter mutation status (2). The gene discussed is IDH1; the disease is central nervous system cancer.